340 related articles for article (PubMed ID: 28427966)
1. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.
Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH
Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S
Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.
Aryal MR; Gosain R; Donato A; Katel A; Chakradhar R; Dhital R; Kouides PA
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):287-292. PubMed ID: 32398463
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.
Irani M; Siegal E; Jella A; Aster R; Padmanabhan A
Transfusion; 2019 Mar; 59(3):931-934. PubMed ID: 30556588
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
Dougherty JA; Yarsley RL
Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.
Warkentin TE
Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032
[No Abstract] [Full Text] [Related]
7. Perioperative Plasma Exchange and Intravenous Immunoglobulin Use for Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient.
Habibi S; Hsieh TC; Khanna S
Am J Case Rep; 2023 Dec; 24():e941865. PubMed ID: 38158651
[TBL] [Abstract][Full Text] [Related]
8. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
Carlsson LE; Santoso S; Baurichter G; Kroll H; Papenberg S; Eichler P; Westerdaal NA; Kiefel V; van de Winkel JG; Greinacher A
Blood; 1998 Sep; 92(5):1526-31. PubMed ID: 9716579
[TBL] [Abstract][Full Text] [Related]
12. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report.
Gonzales M; Pipalia A; Weil A
J Investig Med High Impact Case Rep; 2019; 7():2324709619832324. PubMed ID: 30939936
[TBL] [Abstract][Full Text] [Related]
13. TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.
Zhou Y; Abraham S; Renna S; Edelstein LC; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2315-2323. PubMed ID: 27765766
[TBL] [Abstract][Full Text] [Related]
14. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
Davis KA; Davis DO
Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.
Slavik L; Svobodova G; Ulehlova J; Krcova V; Hlusi A; Prochazkova J; Hutyra M
Clin Lab; 2015; 61(8):1027-32. PubMed ID: 26427148
[TBL] [Abstract][Full Text] [Related]
16. Early high-dose intravenous immunoglobulin for refractory heparin-induced thrombocytopenia with stroke: Two case reports.
Makita N; Ohara T; Tsuji Y; Ueda T; Nakamura T; Mizuno T; Makino M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107032. PubMed ID: 36701852
[TBL] [Abstract][Full Text] [Related]
17. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.
Rollin J; Pouplard C; Sung HC; Leroux D; Saada A; Gouilleux-Gruart V; Thibault G; Gruel Y
Blood; 2015 Apr; 125(15):2397-404. PubMed ID: 25680756
[TBL] [Abstract][Full Text] [Related]
19. Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia.
Lee CSM; Selvadurai MV; Pasalic L; Yeung J; Konda M; Kershaw GW; Favaloro EJ; Chen VM
J Thromb Haemost; 2022 Apr; 20(4):975-988. PubMed ID: 35038779
[TBL] [Abstract][Full Text] [Related]
20. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.
Bachelot-Loza C; Saffroy R; Lasne D; Chatellier G; Aiach M; Rendu F
Thromb Haemost; 1998 Mar; 79(3):523-8. PubMed ID: 9531034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
